21 CFR 520.763a
§ 520.763a Dithiazanine tablets.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 520.763a, § 520.763a Dithiazanine tablets, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87139
- Permanent ID
ys:prov:87139@1- SHA-256
c45bfda0f01d654dd25932ff6fdb5f062854f0330b5023042eb8b7707f156db8
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Each tablet contains 10, 50, 100, or 200 milligrams (mg) dithiazanine iodide.
(b) Sponsor. See No. 069043 in § 510.600(c) of this chapter.
(c) Conditions of use in dogs—(1) Indications for use and amount. Administer orally immediately after feeding as follows:
(i) For large roundworms (Toxocara canis, Toxascaris leonina): 10 mg per pound (/lb) of body weight for 3 to 5 days;
(ii) For hookworms (Ancylostoma caninum, Uncinaria stenocephala) and whipworms (Trichuris vulpis): 10 mg/lb of body weight for 7 days;
(iii) For Strongyloides (Strongyloides canis, Strongyloides stercoralis): 10 mg/lb of body weight for 10 to 12 days;
(iv) For heartworm microfilariae (Dirofilaria immitus): 3 to 5 mg/lb of body weight for 7 to 10 days. Treatment for heartworm microfilariae should follow 6 weeks after therapy for adult worms.
(2) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.